(Q37085495)

18 August 2017

1 reference

title

Burkitt's lymphoma: a model for clinical oncology (English)

1 reference

18 August 2017

0 references

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90397-V

4 December 2022

author name string

E. Bouffet

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1827731

4 December 2022

D. Frappaz

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1827731

4 December 2022

R. Pinkerton

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1827731

4 December 2022

M. Favrot

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1827731

4 December 2022

T. Philip

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1827731

4 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1827731

4 December 2022

publication date

1 January 1991

1 reference

full work available at URL

18 August 2017

https://api.elsevier.com/content/article/PII:027753799190397V?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90397-V

https://api.elsevier.com/content/article/PII:027753799190397V?httpAccept=text/plain

4 December 2022

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90397-V

European Journal of Cancer

4 December 2022

published in

1 reference

18 August 2017

27

1 reference

18 August 2017

4

1 reference

18 August 2017

504-509

1 reference

A sarcoma involving the jaws in African children

18 August 2017

1

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90397-V

Related disease--related cause?

4 December 2022

2

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90397-V

VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA

4 December 2022

4

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90397-V

Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study

4 December 2022

5

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90397-V

CHILDHOOD LYMPHOMA RESEMBLING "BURKITT TUMOR" IN THE UNITED STATES

4 December 2022

7

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90397-V

Correlation between immunoglobulin light chain expression and variant translocation in Burkitt's lymphoma

4 December 2022

8

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90397-V

Marker band in one chromosome 14 from Burkitt lymphomas.

4 December 2022

9

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90397-V

A new translocation in Burkitt's tumor cells

4 December 2022

10

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90397-V

2/8 translocation in a Japanese Burkitt's lymphoma

4 December 2022

11

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90397-V

Improved survival rate in children with stage III and IV B cell non-Hodgkin's lymphoma and leukemia using multi-agent chemotherapy: results of a study of 114 children from the French Pediatric Oncology Society

4 December 2022

17

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90397-V

Effective multiagent chemotherapy in children with advanced B-cell lymphoma: who remains the high risk patient?

4 December 2022

18

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90397-V

Curability of Burkitt's lymphoma with high-dose cyclophosphamide-high-dose methotrexate therapy and intrathecal chemoprophylaxis

4 December 2022

19

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90397-V

Results of treatment of advanced-stage Burkitt's lymphoma and B cell (SIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine

4 December 2022

20

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90397-V

Phase II study of cytarabine and etoposide in children with refractory or relapsed non-Hodgkin's lymphoma: a study of the French Society of Pediatric Oncology

4 December 2022

22

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90397-V

Immunoglobulin and glucose-6-phosphate dehydrogenase as markers of cellular origin in Burkitt lymphoma

4 December 2022

23

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90397-V

Expression of an Antigen Associated With Acute Lymphoblastic Leukemia in Human Leukemia-Lymphoma Cell Lines 2

4 December 2022

27

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90397-V

Activation and somatic mutation of the translocated c-myc gene in burkitt lymphoma cells.

4 December 2022

29

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90397-V

Lymphoma development in mice and humans: diversity of initiation is followed by convergent cytogenetic evolution

4 December 2022

31

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90397-V

Presenting Clinical Features of Burkitt's Lymphoma in Ghana, West Africa

4 December 2022

33

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90397-V

Abdominal Burkitt-type lymphomas in Algeria

4 December 2022

37

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90397-V

Burkitt's lymphoma in Europe

4 December 2022

39

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90397-V

Burkitt-type lymphoma in France among non-Hodgkin malignant lymphomas in Caucasian children

4 December 2022

41

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90397-V

Treatment results of 54 American patients with Burkitt's lymphoma are similar to the African experience

4 December 2022

42

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90397-V

Abdominal Burkitt's lymphoma: role of early aggressive surgery

4 December 2022

44

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90397-V

The treatment of localized non-Hodgkin's lymphoma in children: a report from the Children's Cancer Study Group

4 December 2022

45

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90397-V

A new therapy schedule for pediatric non-Hodgkin lymphoma toxicity with preliminary results

4 December 2022

48

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90397-V

Childhood non-Hodgkin's lymphoma. The results of a randomized therapeutic trial comparing a 4-drug regimen (COMP) with a 10-drug regimen (LSA2-L2)

4 December 2022

49

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90397-V

The role of massive therapy with autologous bone marrow transplantation in Burkitt's lymphoma

4 December 2022

53

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90397-V

High-dose therapy and autologous bone marrow transplantation in partial remission after first-line induction therapy for diffuse non-Hodgkin's lymphoma

4 December 2022

54

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90397-V

Treatment of malignant lymphoma in 100 patients with chemotherapy, total body irradiation, and marrow transplantation.

4 December 2022

55

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90397-V

High-dose polychemotherapy with autologous bone marrow transplantation in children with relapsed lymphomas

4 December 2022

56

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90397-V

Massive therapy and autologous bone marrow transplantation in pediatric and young adults Burkitt's lymphoma (30 courses on 28 patients: a 5-year experience).

4 December 2022

57

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90397-V

High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma.

4 December 2022

59

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90397-V

4 December 2022

Identifiers

1 reference

18 August 2017

1 reference